$LGN

Legence Sets Second Quarter 2026 Earnings Release Date and Webcast Schedule

Legence Corp. (Nasdaq: LGN) said it will report second-quarter 2026 results for the quarter ended June 30, 2026 on Aug. 13, 2026, before market open. The company will hold an earnings conference call and webcast that day at 10:00 a.m. ET, with a replay available on its website through Sept. 13, 2026.

Original reporting
Published Jul 27, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 12:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LGN
Neutral
medium confidence
Mentioned
$LGN
Relevance
5/10
alphai data visualization · based on gazettextra.com
Decision brief

The 30-second read

$LGNNeutralMed
01

Why it matters

The primary tradable element is the earnings timing, which can drive pre-earnings positioning, implied volatility changes, and event-driven hedging.

02

Market read

A defined earnings date and webcast time for LGN can be used to plan event risk and liquidity/volatility strategies.

03

What to watch

Watch for any subsequent filings (8-K) or investor presentation updates around Aug. 13 that could introduce new guidance or risk disclosures not present here.

Relevance 5/10Novelty 5/10Timing: ahead of Aug. 13, 2026 pre-market earnings release

Background

Legence is a provider of engineering, consulting, installation, and maintenance services for mission-critical building systems.

Company-level read

Ticker impact

$LGNNeutralMedium confidence
Context

Legence (LGN) set its Q2 2026 earnings release for Aug. 13, 2026, before the open, with a 10:00 am ET webcast.

Expected impact

Likely modest pre-earnings volatility and options activity into Aug. 13; direction depends on the Q2 print and any guidance commentary.

Evidence & confidence

The article discloses only the timing and webcast details, not results, guidance, or new fundamentals.

Market effects

Limited sector read-through because the release timing is not accompanied by industry datapoints or guidance.

No specific regional market linkage beyond US small/mid-cap earnings calendar effects.

No global implications mentioned.

Counterpoint

Because the article contains only scheduling details, traders may treat it as low signal and focus on broader market factors rather than LGN-specific positioning.

Key entities

  • Legence Corp.

    Nasdaq-listed engineering and MEP services provider that scheduled its Q2 2026 earnings release and webcast.

Related articles

$LGNMedAI 8/10

Here’s What Lifted Legence Corp. (LGN) in Q1

Fred Alger Management’s “Alger Weatherbie Specialized Growth Fund” Q1 2026 investor letter said the fund’s Class A shares lagged the Russell 2500 Growth Index. It cited sector contributions from Information Technology and Consumer Staples, with Health Care and Financials detracting. The letter highlighted Legence Corp. (LGN), noting Q1 revenue up 105% to $1.038 billion and that management raised full-year guidance.

$RIVNMed

What Rivian And Lucid's Latest Earnings Say About The EV Startup Race

The article compares Rivian and Lucid after their 2021 IPOs, focusing on recent earnings. Lucid reported $405 million revenue in the quarter, with net loss widening to over $1 billion, and announced an “operational reset” tied to $1.4 billion cash savings in 2026, plus $3 billion liquidity. Rivian reported $1.66 billion revenue last quarter and raised 2026 delivery guidance to 65,000-70,000 vehicles.

$LNGMedAI 8/10

Cheniere Energy Q2 Earnings Call Highlights

Cheniere Energy’s Q2 earnings call said updated guidance includes about $300 million from additional expected production, with Corpus Christi Stage 3 over 98% complete and Train 7 entering commissioning. The company signed a roughly $4.7 billion EPC contract for Sabine Pass Phase I, targeting FID in early next year. Cheniere repurchased 2.2 million shares for $550 million and declared a $0.555 dividend.

$CCMed

Why Chemours Plunged on Wednesday

Chemours (NYSE: CC) shares fell 18.7% after its Q2 earnings. The company reported slight revenue decline and adjusted EPS of $0.42, down 31% year over year, meeting expectations. Management cited lower Optane refrigerant sales due to supply-chain inventory and the wind-down of the SPS Capstone business. Full-year growth guidance remains 1% to 5%.

$INBKMedAI 8/10

First Internet Bancorp (INBK) Q2 2026 Earnings Call Transcript

First Internet Bancorp (INBK) reported Q2 2026 revenue of $41.1 million, up 23%, and non-GAAP diluted EPS of $0.27 versus $0.02 a year earlier. Net interest margin (FTE) rose to 2.47%. Credit costs eased, but net charge-offs were $16.9 million. Full-year 2026 EPS guidance is $2.35 to $2.45.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.